Mylan-ciprofloxacin - 250 Mg

Mylan-Ciprofloxacin 250 mg Recall Summary Mylan-Ciprofloxacin 250 mg tablets are being recalled across Canada due to a product quality and safety issue. This antibiotic medication is distributed throughout Canada. The FDA has classified this as a Class I recall, which indicates a serious quality concern.

Reason

Product quality - Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2013-06-06

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/eae76521-d5e8-486f-88f4-2242ce687f21